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Objectives. This study sought o achieve an understanding of 
the true structural heterogeneity of hypertrophic ardiomyopathy. 
Background. The diversity and clinical significance of the 
morphologic expression of hypertrophic ardiomyopathy have not 
been fully defined within this broad disease spectrum. 
Methods. Patterns of left ventricnlar hypertrophy were charac- 
terized by two-dimensional echocardiography in a large study 
cohort of 600 patients (7 to 79 years old, mean age 45; 393 [66%] 
men) consecutively studied at two referral centers. 
Results. Left ventricular wall thickness was 15 to 52 mm (mean 
[-SD] 22.3 - 5). A multitude of patterns of asymmetric left 
ventricular hypertrophy were identified, with the most common 
showing diffuse involvement of substantial portions of both ven- 
tricular septum and free wall. Of 16 possible patterns of left 
ventricular hypertrophy, 12 (78%) were identified among the 600 
patients. Hypertrophy most commonly involved two left ventricn- 
lar segments (228 patients [38%]) or three or more segments (202 
patients [34%]), but was also localized to one segment ina substan- 
tiai number of patients (170 [28%]). The anterior portion of the 
ventricular septum was the region of the left ventricle that most 
frequently showed thickening (573 patients [96%]), and was also the 
predominant site of hypertrophy in most patients (492 patients 
[83%]). Patterns of wall thickening that were either concentric (i.e., 
symmetric) or confined to the apex were particularly uncommon (in 
1% each). 
Conclusions. 1) In hypertrophic cardiomyopathy, the distribu- 
tion of left ventrieuiar hypertrophy is characteristically asymmet. 
tic and particularly heterogeneous, encompassing most possible 
patterns of wall thickening, from extensive and diffuse to mild and 
segmental, and with no single morphologic expression considered 
typical or classic. 2) A greater extent of left ventricular hypertro- 
phy was associated with younger age and more marked mitral 
valve systolic anterior motion and outflow obstruction but showed 
no relation to either magnitude of symptoms or gender. 
(J Am CoU Cardiol 1995;26:1699-708) 
Hypertrophic cardiomyopathy is a primary, often genetically 
transmitted, cardiac disease with a broad clinical and morpho- 
logic spectrum that has been the subject of considerable 
interest and study (1-7). Of particular note is the phenotypic 
variability of hypertrophic cardiomyopathy in which the extent 
and distribution of left ventricular hypertrophy may differ 
widely among patients (2,3,7-23). However, the frequency with 
which different patterns of left ventricular hypertrophy occur in 
the hypertrophic cardiomyopathy patient population, as well as 
the clinical significance of these phenotypic expressions a  they 
may relate to patient age, gender, magnitude ofsymptoms and 
left ventricular outflow tract obstruction, have not yet been 
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completely defined in smaller patient groups (2,3,8,10). There- 
fore, the availability of a large cohort of 600 patients with 
hypertrophic cardiomyopathy studied consecutively with two- 
dimensional echocardiography afforded the opportunity for an 
enhanced assessment ofthe spectrum and importance ofthese 
morphologic forms with respect o selected clinical and demo- 
graphic features of the disease. 
Methods  
Study patients. Registries of the echocardiography labora- 
tories were reviewed for the year 1989 at the National Heart, 
Lung, and Blood Institute (NHLBI) and for 1989 to 1992 at the 
University Hospital RWTH (Aachen, Germany). Complete 
transthoracic two-dimensional echocardiographic studies were 
available from 671 consecutively studied patients with hyper- 
trophic cardiomyopathy at the two institutions. For each 
patient the diagnosis of hypertrophic cardiomyopathy was 
established by the echocardiographic demonstration f a hy- 
pertrophied, nondilated left ventricle in the absence of another 
systemic or cardiovascular disease capable of producing the 
magnitude of hypertrophy observed (24). Consequently, pa- 
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tients judged to have left ventricular hypertrophy secondary, to
systemic hypertension were not part of the study group. 
Of the 671 patients with hypertrophic cardiomyopathy, 71 
were excluded for the following reasons: 1) age <7 or >80 
years; 2) echocardiographic studies of technical quality inade- 
quate to reliably assess the distribution of left ventricular 
hypertrophy; 3) documented hemodynamically and clinically 
significant aortic or mitral valvular or coronary artery disease; 
4) availability of echocardiograms obtained only after myoto- 
my-myectomy operation; or 5) evidence of the "end-stage" 
phase of hypertrophic cardiomyopathy (25). Consequently, the 
remaining 600 patients (500 from the NHLBI, 100 from 
University Hospital RWTH) comprised the final study group 
(7 to 79 years old, mean age [±SD] 45 _ 17; 49 patients <20 
years old [8%], 125 patients >60 years old [21%]; 393 men 
[66%]). Of the 600 patients, 182 (30%) had no functional 
limitation, 282 (47%) had mild symptoms (New York Heart 
Association functional class 1I), and 136 (23%) had moderate 
to severe limitations (classes III and IV). 
Echocardiograpbic methods. Echocardiographic studies 
were performed with commercially available (Hewlett- 
Packard, model 77020 AC) ultrasound scanners and 2.5- or 
3.5-MHz transducers. Two-dimensional images were obtained 
in multiple cross-sectional p anes using standard transducer 
positions (26). Images were recorded on 0.5- or 0.75-in. format 
videotapes to facilitate real-time, slow-motion and freeze- 
frame analysis and to allow serial review and rapid comparison 
of studies. M-mode echocardiograms were derived under 
direct anatomic visualization from the two-dimensional images 
and recorded on a strip chart at 100 mm/s. Chamber dimen- 
sions were measured from M-mode echocardiograms accord- 
ing to published recommendations (27). 
Magnitude and distribution of left ventricular hypertrophy 
was assessed primarily in the parasternal short-axis plane, 
although parasternal long-axis and apical views were also used 
to integrate the information obtained from the short-axis 
images (28). To assess patterns of left ventricular hypertrophy 
in the short-axis plane, the ventricle was divided into four 
relatively equal segments that comprised the anterior and 
posterior ventricular septum and lateral and posterior f ee wall 
(11,28,29). Distribution of left ventricular hypertrophy was also 
analyzed in the basal-apical ( ongitudinal) plane using the 
parasternal long-axis and apical views; the ventricle was di- 
vided into two segments, the proximal (basal) portion extend- 
ing from cardiac base to the inferior margins of mitral eaflets, 
and the distal (apical) portion visualized caudal to the mitral 
leaflets. A segment of the left ventricular wall was judged to be 
hypertrophied if >50% of its area was ->15 mm thick at 
end-diastole (Fig. 1). 
Assessment of left ventricnlar hypertrophy. Patterns of 
hypertrophy were described in two ways: 1) Overall extent was 
defined with regard to the number of thickened left ventricular 
segments: one segment = mild; two segments = moderate; 
three or four segments = severe. 2) Alternatively, hypertrophy 
was described utilizing our previous classification (8): a) 
type I = confined to anterior segment of ventricular septum; b) 
A 
R-q--L 
P 
POSTERIOR VS'-, ~ANT~_..RIOR 
VS 
r,/! 
~ POSTERIOR FREE WALL 
Figure 1. Segments of left ventricular wall visualized by two- 
dimensional echocardiography in the short-axis view. The points of 
insertion of right ventricle into the left ventricle constitute the 
anatomic landmarks dividing the ventricular septum (VS) from the left 
ventricular free wall. A = anterior; L = left; P = posterior; R = right. 
Reproduced with permission fthe American Heart Association. 
type H = involved anterior and posterior septum; c) type III = 
substantial portions of both septum and free wall; and d) 
type/V = regions other than the basal and anterior septum. 
Systolic anterior motion of mitral valve. Magnitude of left 
ventricular outflow tract obstruction had been measured at 
cardiac atheterization r by continuous wave Doppler (30,31) 
in close proximity to the time of echocardiographic study in 
only a minority of the 600 study patients. Consequently, we 
related the distribution of left ventricular hypertrophy directly 
to the magnitude and duration of systolic anterior motion of 
the mitral valve (32). Magnitude of systolic anterior motion of 
mitral valve was assessed using a modification of the grading 
system of Gilbert et al. (32): mild --- approached ventricular 
septum, but without septal contact; moderate = brief mitral- 
septal contact; severe = prolonged septal contact, >30% of 
echocardiographic systole. 
Statistical analysis. Data are expressed as mean value _ 
SD. Differences between continuous variables were assessed 
with the unpaired Student test and one-way analysis of 
variance. A Bonferroni test was applied to correct for multiple 
comparisons, where appropriate. Proportions were compared 
by the chi-square or Fisher exact ests. Selected variables were 
compared using linear regression analysis. Univariate and 
multivariate regression analyses (33) were performed to assess 
the degree to which the extent of left ventricular hypertrophy 
(i.e., number of hypertrophied left ventricular segments) was 
associated with gender and age. 
Resu l ts  
Distribution of left ventricular hypertrophy. General anal- 
ysis. Maximal eft ventricular wall thicknesses ranged from 15 
to 52 mm (mean 22 -- 5) and were >30 mm in 68 patients 
(11%) and -<20 mm in 269 (45%). When analyzed with regard 
to the distribution of left ventricular wall thickening, a wide 
variety, of patterns were present in the overall study group, 
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Table 1. Patterns of Left Ventricular Hypertrophy in 600 Patients 
With Hypertrophic Cardiomyopathy 
Hypertrophied LV Segment No. of Pts Percent of Pts 
AVS + PVS 182 31 
AVS 150 25 
AVS + PVS + LFW 100 17 
AVS + PVS + LFW - PFW 98 17 
AVS + LFW 43 7 
PVS 8 1 
Apex 7 1 
PVS + LFW + PFW 4 0.7 
LFW 3 0.5 
PFW 2 0.3 
PVS + LFW 2 0.3 
LFW + PFW 1 0.2 
AVS + LFW + PFW 0 0 
AVS + PVS + PFW 0 0 
AVS + PFW 0 0 
PVS + PFW 0 0 
AVS : anterior ventricular septum; HCM = hypertrophic cardiomyopathy; 
LFW = lateral free wall; LV - left ventricular; PFW : posterior free wall; Pts : 
patients; PVS = posterior ventricular septum. 
some rather uncommon i frequency (Table 1, Fig. 2 to 5). Of 
the 16 possible patterns of hypertrophy, 12 ( 75 %) were present 
among the 600 study patients (Table 1). Each of the four 
patterns not encountered in the present analysis required 
thickening of the posterior flee wall, the region least com- 
monly hypertrophied in hypertrophic cardiomyopathy (8). 
The anterior ventricular septum was the most frequently 
hypertrophied segment of the left ventricle (573 [96%] of 600 
patients). Less commonly involved was posterior septum (394 
patients [66%]) and lateral free wall (251 patients [42%]); the 
posterior free wall was usually preferentially spared from the 
hypertrophic process and was thickened in only 105 patients 
(18%). 
Furthermore, in most patients (492 patients [83%]) the 
anterior ventricular septum was the predominant region of 
hypertrophy (Fig. 2, A, B and D; Fig. 4, A, C and D); much less 
commonly, wall thickening was predominant in the posterior 
septum (56 patients [10%]) (Fig. 2F, 4A, 5B), lateral wall (26 
patients [4%]) and posterior wall (11 patients [2%]) (Fig. 6). 
The prominent asymmetry and heterogeneity of hypertrophy 
present in the study patients was evident by such variable 
locations of wall thickening within the left ventricle as well as 
the sharp, abrupt ransitions in wall thickness in which sub- 
stantially hypertrophied regions were frequently contiguous 
with normal areas (Fig. 2, C and E; Fig. 4, A to D and F). 
Segmentalanalysis (Table 2, Fig. 7). In 170 (28%) of the 600 
study patients, wall thickening was confined to one segment of 
the left ventricular wall (Fig. 2E; Fig. 4, A, B, D and F; Fig. 
5D). In 150 of these 170 patients only the anterior portion of 
the ventricular septum was hypertrophied (morphologic type 1 
pattern in the previous classification of Maron et al. [8]); these 
included 57 patients in whom hypertrophy discretely involved 
only the most basal portion of anterior septum ("septal bump" 
in the parasternal long axis) (Fig. 3C). 
In the remaining 20 patients, more unusual patterns of wall 
thickening sparing the anterior septum were present (posterior 
septum in eight patients, lateral free wall in three [Fig. 2El, 
posterior free wall in two [Fig. 4F], apex in seven [Fig. 5D]), 
with each corresponding to morphologic type IV (8). The latter 
seven patients met our strict morphologic criterion for "apical 
hypertrophic cardiomyopathy" by virtue of hypertrophy con- 
fined to the most apical portion of left ventricle (below 
papillary muscle level) (18), as visualized in standard four- and 
two-chamber views. 
In 228 (38%) of the 600 study patients, wall thickening 
involved two segments of the left ventricular wall. Most com- 
monly (in 182 patients), both the anterior and posterior portions 
of the ventricular septum were thickened, and the free wall was 
spared (Fig. 2G, Fig. 5C), corresponding to the type II pattern (8). 
Only the anterior septum and the contiguous portions of the 
lateral free wall were involved in 43 patients (Fig. 4B), and the 
lateral and posterior free wall in 1 patient. The remaining two 
patients howed hypertrophy of two noncontiguous segments, 
that is, the posterior septum and lateral free wall (Fig. 5B). 
In 202 (34%) of the 600 study patients, wall thickening was 
particularly diffuse involving three or all four segments of left 
ventricular wall, corresponding to the type III pattern (8) (Fig. 
2, A, B and D). Typically, these patients had extensive wall 
thickening involving substantial portions of the anterior and 
posterior ventricular septum and lateral free wall and prefer- 
entially sparing either all of the posterior free wall (100 
patients) or only the basal portion of posterior wall (94 
patients). Also, this distribution of hypertrophy was often 
characterized in the short-axis plane by a "tapered" appear- 
ance in which the anterior septum (at the 12 o'clock position) 
was predominant, the posterior septum and lateral free wall 
less so and posterior free wall (at 6 o'clock) representing the 
thinnest portion (34) (Fig. 2, A, B and D). Eight patients with 
diffuse hypertrophy were judged to have truly concentric 
(symmetric) distribution of hypertrophy in which all hypertro- 
phied segments were thickened to a similar degree (1% of the 
600 study patients) (Fig. 5A). 
Some portion of the ventricular septum was involved in the 
hypertrophic process in 587 patients (98%); in only 13 patients 
(2%) (with hypertrophy confined to lateral or posterior free 
wall or true apex) was the septum not thickened. 
Relation of distribution of hypertrophy to wall thickness. 
A direct relation was present between the number of hyper- 
trophied left ventricular segments and maximal wall thickness 
(Table 2, Fig. 8). With one, two and three or more left 
ventricular segments involved, wall thicknesses were 20 _+ 3, 
22 -+ 4 and 25 _ 6 ram, respectively. Similar relations between 
distribution of hypertrophy and wall thickness were defined for 
morphologic types 1 (20 _+ 3 mm), II (22 _+ 5 mm) and III 
(24 _+ 6 ram, p < 0.001). 
Areas of massive wall thickening (Fig. 2A, Fig. 3A) (->30 mm) 
were present in 47 (23%) of 202 patients with three or more 
segments involved, in 18 (8%) of 228 with two segments involved 
and in only 3 (2%) of 170 with hypertrophy confined to one 
segment. In contrast, relatively mild wall thickening (Fig. 2E; 
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Figure 2. Variability of patterns ofleft ventricular 
hypertrophy in patients with hypertrophic cardio- 
myopathy, shown in a composite ofdiastolic stop- 
frame images inthe parasternal short-axis plane. A, 
B and D, Wall thickening is diffuse, involving 
substantial portions of ventricular septum and free 
wall. At the papillary muscle l vel (A), all segments 
of the left ventricular wall are hypertrophied, in- 
cluding the posterior free wall (PW), but the 
pattern of thickening is asymmetric with the ante- 
rior portion of ventricular septum (VS) massive 
(i.e., 50 mm). B, Hypertrophy is diffuse, involving 
three segments of the left ventricle but with the 
posterior wall spared and thin (<10 mm) (arrow- 
heads) and with particularly abrupt changes inwall 
thickness evident (arrows). C, Marked hypertrophy 
in a pattern distinctly different from that in A, B 
and D in which the thickening ofthe posterior wall 
is predominant, and the ventricular septum is of 
nearly normal thickness. D,Diffuse distribution f
hypertrophy involving three segments of the left 
ventricle similar to that in B but without sharp 
changes inthe contour of the wall. E, Hypertrophy 
predominantly of lateral free wall and only a small 
portion of contiguous anterior septum (arrows). F, 
Hypertrophy predominantly of posterior ventricu- 
lar septum (PVS) and, to a lesser extent, the 
contiguous portion of the anterior septum. G, 
Thickening of anterior and posterior septum to a 
similar degree but with sparing of the free wall. 
Calibration dots are 1 cm apart. AML = anterior 
mitral eaflet; LFW = lateral free wall; PML = 
posterior mitral leaflet. 
Fig. 3C; Fig. 4, A, B, D and F; Fig. 5D) (---20 rnm) was identified 
in 115 patients (68%) with one segment involved, in 99 patients 
with two segments involved (43%) and in only 55 patients with 
diffuse hypertrophy (27%) in three or more segments. 
The 68 study patients with particularly substantial left ventric- 
ular hypertrophy (thickness ->30 mm), compared with the 269 
patients with relatively mild thickening (-<20 ram), were younger 
(31.9 + 16vs. 49.5 _+ 15 years old, p < 0.001) and more frequently 
showed systolic anterior motion of mitral valve (53% vs. 25%, p < 
0.001) but did not differ with respect o gender (each 68%) or 
presence of severe symptoms (16% vs. 22%). 
Distribution of hypertrophy in longitudinal plane. Three 
patterns of wall thickening were evident in the longitudinal 
plane and occurred with similar frequency in the overall study 
group. Hypertrophy was predominant in the proximal (basal) 
portion of left ventricle in 210 patients (29%) (Fig. 3C), in the 
distal (apical) ventricle in 203 patients (Fig. 3, B and D; Fig. 5, 
D and E) and relatively equal in the proximal and distal 
regions in 217 patients (36%) (Table 2, Fig. 3A). Proximal 
hypertrophy was associated with relatively mild wall thickening 
(mean 20.7 _+ 3 ram) and occurred in older patients (52 _+ 14 
years) compared with distal hypertrophy (24 _+ 6 mm and 39 _+ 
16 years, p < 0.001). 
Distribution of hypertrophy and mitral valve systolic ante- 
rior motion. Marked systolic anterior motion of mitral valve 
(with prolonged mitral-septal contact) was more common in 
patients with diffuse and extensive hypertrophy involving two 
to four left ventricular segments (162 [38%] of 430 patients, 
p < 0.001) than in patients with only one hypertrophied 
segment (42 [25%] of 170) (Table 2, Fig. 9). Similarly, patients 
with marked systolic anterior motion of mitral valve had 
greater wall thicknesses (24 _+ 5 ram) than those with no or 
mild systolic anterior motion of mitral valve (22 _+ 5 mm, p < 
0.001). Marked mitral valve systolic anterior motion was also 
more commonly associated with predominantly proximal hy- 
pertrophy (62 [36%] of 173 patients) than with distal hyper- 
JACC Vol. 26, No. 7 KLUES ET AL. 1703 
December 1995:1699-7(18 LV HYPERTROPHY IN HYPERTROPHIC CARDIOMYOPATHY 
Figure 3. Variability in distribution and extent of ventricular septal 
thickening asshown in a composite ofparasternal long-axis stop-frame 
images obtained in diastole. A, Massive asymmetric hypertrophy of 
ventricular septum (VS) with wall thickness >50 mm. B, Heteroge- 
neous pattern of septal thickening, with distal portion substantially 
thicker than the proximal region at mitral valve level. C, Hypertrophy 
sharply confined to the basal (proximal) septum just below the aortic 
valve (arrows). D, Distal septal thickening (arrows) and particularly 
abrupt transition tothin proximal septum (<10 mm) (arrowheads). E, 
"Inverted" pattern of hypertrophy in which distal anterior ventficular 
septum is only mildly thickened, but posterior free wall (PW) is 
substantially thickened (to 40 mm). Calibration dots are 1 cm apart. 
Ao = aorta; AML = anterior mitral leaflet; LA = left atrium; LV = 
left ventricle. 
Distribution of hypertrophy and clinical variables. Age. 
The pattern and magnitude ofleft ventricular hypertrophy was 
inversely related to patient age (at the time of the echocardio- 
graphic study) (Table 2, Fig. 10). For example, patients were 
51 +_ 15, 45 __ 16 and 40 -- 18 years old with one, two or three 
or more segments hypertrophied, respectively. Also, linear 
regression analysis howed an inverse relation between age and 
maximal left ventricular wall thickness (r = 0.343, p < 0.001). 
Gender. No differences were identified between male and 
female patients with regard to the extent of left ventricular 
hypertrophy (Table 2, Fig. 7). Men and women showed similar 
maximal wall thickness (22 + 4 vs. 22 +_ 4 ram, p > 0.05) and 
number of hypertrophied segments involved (one segment, 
30% vs. 26%; two segments, 37% vs. 40%; three or more 
segments, 33% vs. 34%, p > 0.05). 
Functional class. No relation was evident between magni- 
tude of symptoms and either extent of hypertrophy ormaximal 
wall thickness (Table 2). Average functional class was 2.0, 1.9 
and 2.0 in patients with one, two or three or more hypertro- 
phied segments (p > 0.05). Mean wall thickness was 22 + 5, 
23 _~: 5 and 22 + 4, in patients in functional classes I, II or III 
and IV, respectively (p > 0.05). 
Univariate analysis howed extent of left ventrieular hyper- 
trophy to have a significant relation to patient age (p < 0.001) 
but not to gender. Multivariate regression analysis howed age to 
be the only independent variable associated with extent of 
hypertrophy (p < 0.0001). 
t rophy (44 [22%] of 203, p < 0.001). Anomalous direct 
insertion of papillary muscle into the anterior leaflet (35) was 
judged likely to be present in 26 patients (4%). 
Discuss ion  
Diversity of left ventricular hypertrophy. The findings of 
the present detailed echocardiographic analysis of 600 consec- 
utively studied patients with hypertrophic ardiomyopathy 
from two major referral institutions underlines the vast diver- 
sity of morphologic abnormalities encountered within this 
disease spectrum. These observations also support the concept 
that no single pattern of left ventricular hypertrophy in hyper- 
trophic cardiomyopathy can be considered "classic" or typical 
of the disease. Indeed, we found that our 600 patients encom- 
passed most possible patterns of hypertrophy (1,2,8,10,16-18), 
ranging from localized and relatively mild wall thickening 
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Figure 4. Illustration ofthe broad morphologic spec- 
trum of hypertrophic cardiomyopathy with two- 
dimensional cross-sectional echocardiography. A to E, 
Parasternal short-axis plane. F, Apical four-chamber 
view. In A, B and D, there is substantial variability in
the location of relatively mild segmental wall thicken- 
ing within the anterior portion of the ventricular 
septum (A and D) and contiguous anterolateral free 
wall (B) (arrows). In C, more marked thickening ofthe 
anterior septum (arrows) is contiguous with a normal 
region of posterior septum, demonstrating a particu- 
larly sharp and abrupt ransition i  wall thickness, 
forming aright-angled contour (arrowheads). E, Pre- 
dominant and marked hypertrophy of the posterior 
ventricular septum (arrows); the adjacent anterior 
septum ismuch thinner. F,Wall thickening confined to 
the posterobasal free wall directly behind the mitral 
valve (arrowheads). AML = anterior mitral eaflet; 
LA = left atrium; LV = left ventricle; VS = ventric- 
ular septum. 
involving any one of the left ventricular wall segments (or 
apex) to marked and diffuse hypertrophy ofall portions of the 
left ventricle; wall thicknesses averaged >20 mm, and ranged 
up to >50 mm, constituting the most extreme form of hyper- 
trophy evident in any cardiac disease (17). 
Left ventricular hypertrophy in hypertrophic cardiomyopa- 
thy nearly always involves ome portion of ventricular septum 
and, most frequently, it is the anterior septum that is most 
prominently thickened. Furthermore, asymmetry is an almost 
invariable feature of wall thickening in hypertrophic cardio- 
myopathy, in that all regions of the left ventricle are rarely of 
identical or similar thickness. Indeed, in -66% of the present 
overall patient group, asymmetry was particularly obvious with 
wall thickening involving only one or two of the four left 
ventricular segments. In patients with more diffuse hypertro- 
phy, the observed asymmetry was frequently due to sparing of 
a relatively small portion of the left ventricular wall (usually 
the posterior free wall). 
Also, in our patients, the pattern of hypertrophy was often 
strikingly heterogeneous, showing marked ifferences in wall 
thickness between contiguous segments, or with hypertrophy 
involving noncontiguous segments of left ventricle (with inter- 
positioned areas of normal thickness). Transitions between 
thickened and nonthickened regions were commonly sharp 
and abrupt, not infrequently creating right-angled contours of 
the ventricular wall, unique to the degree with which these 
findings are present in patients with hypertrophic cardiomyop- 
athy. Conversely, truly symmetric (i.e., concentric) hypertrophy 
was also part of the morphologic spectrum of hypertrophic 
cardiomyopathy, although present in only a very small minority 
of our patients (~1%). Other investigators (3) have reported a 
more frequent occurrence of the symmetric form of hypertro- 
phy in hypertrophic cardiomyopathy, apparently due to the use 
of alternative morphologic riteria in which diffuse patterns 
with only segmental reas of asymmetry were judged to be 
concentric. Some patterns of left ventricular hypertrophy (e.g., 
massive and diffuse, involving noncontiguous portions of left 
ventricle, or confined to sites uch as posterior septum, lateral or 
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Figure 6. Location of predominant si e of left ventricular wall thick- 
ening as assessed in 592 patients with hypertrophic cardiomyopathy 
and asymmetric patterns ofhypertrophy (eight patients with concentric 
hypertrophy were excluded from this analysis). The predominant 
hypertrophied segment was defined as that containing the thickest 
portion of the wall or that segment showing the most extensive 
involvement (if two or more segments were of the same maximal 
thickness). FW = free wall; VS = ventricular septum. 
Figure 5. Heterogeneity in patterns ofleft ventricular hypertrophy in 
five patients with hypertrophic cardiomyopathy. A, B and C, Diastolic 
stop-frame images obtained inthe parasternal short-axis plane. I) and 
E, Apical four-chamber views. In A, relatively mild hypertrophy in a 
concentric (symmetric) pattern with each segment ofseptum and free 
wall having similar or identical thickness (paired arrows). B, "Butter- 
fly" pattern with prominent indentation (arrow) and localized area of 
thinning interpositioned at the 11 o'clock position between adjacent 
thicker areas of ventricular septum. C, Hypertrophy of entire ventric- 
ular septum (VS) and sparing of free wall. D, Myocardial hypertrophy 
confined to left ventricular pex (asterisk). E, Image from another 
patient with hypertrophy of the apex, but also diffusely involving the 
ventricular septum and free wall. Calibration marks are 1 cm apart. 
AVS = anterior ventricular septum; LA = left atrium; LFW = lateral 
free wall; LV = left ventricle; PVS = posterior ventricular septum. 
posterior f ee wall or apex) are distinctive; they appear unique 
to primary hypertrophic cardiomyopathy b virtue of being 
uncharacteristic of other cardiac diseases associated with sec- 
ondary left ventricular hypertrophy such as systemic hyperten- 
sion (36). 
The myriad patterns of left ventricular hypertrophy oc- 
curred in our large patient group with differing frequencies. 
The most common pattern involved iffuse distribution of wall 
thickening in both septum and free wall (i.e., -40%). Al- 
though perhaps not generally recognized as part of the hyper- 
trophic cardiomyopathy disease spectrum, localized or seg- 
mental patterns of hypertrophy (most commonly of anterior 
septum) nevertheless comprised a substantial minority of our 
patients (i.e., 28%). Within the latter patient group is a small 
subset with wall thickening confined to the most apical portion 
of left ventricle ("apical hypertrophic cardiomyopathy") (12- 
15,18,37); that only 1% of our patients had this morphologic 
form strongly suggests that it may be much less common 
among North American than Japanese patients (5). However, 
it is worth emphasizing that this unique distribution of apical 
hypertrophy should be distinguished from more common 
morphologic patterns in which wall thickening is more prom- 
inent in the distal compared to the proximal portion of left 
ventricle. 
Relevance to clinical features. The magnitude of left ven- 
tricular hypertrophy in our patients howed certain clinically 
relevant associations compared with demographic features or 
disease variables. For example, more extensive l ft ventricular 
hypertrophy was inversely associated with patient age (29). In 
younger patients (<30 years old), left ventricular hypertrophy 
was more frequently diffuse, involving substantial portions of 
septum and free wall, and associated with markedly increased 
wall thickness; conversely, older patients more frequently 
showed localized and relatively mild wall thickening confined 
to one left ventricular segment. Furthermore, a multivariate 
stepwise regression analysis howed a strong relation between 
wall thickness and age, even after adjusting for other indepen- 
dent variables. The explanation for this inverse relation be- 
tween age and magnitude of hypertrophy is uncertain but 
possibly due to higher rates of premature death in younger 
patients with severe hypertrophy (38) or, alternatively, to 
progressive wall thinning occurring gradually over a long 
period of time in many patients (11,22,25,39). In addition, the 
presence of marked systolic anterior motion of mitral valve 
(and thereby dynamic outflow obstruction) (32,40-44) was 
associated with more marked and proximally located ventric- 
ular septal and free wall hypertrophy; these findings are 
consistent with the observation that thickening of the anterior 
basal septum (associated with reduced left ventricular outflow 
tract area) is a morphologic determinant of outflow obstruc- 
tion (45). 
Relation to gender. Men and women with hypertrophic 
cardiomyopathy didnot differ with respect o the morphologic 
expression of their disease, either in terms of maximum wall 
thickness, distribution of left ventricular hypertrophy or the 
frequency with which the most marked phenotypic disease 
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Table 2. Comparison of Clinical and Echocardiographic Data in 600 Patients With Hypertrophic Cardiomyopathy Analyzed With Respect o 
Number of Hypertrophied Left Ventricular Segments 
p Three or More 
Overall Study One Segment Value Two Segments p Value Segments p Value 
Group [n = 170 (1 vs. 2 [n = 228 (2 vs. ->3 [n = 202 (l vs. ->3 
[n 600] (28%)1 segments) (38%)] segments) (34%)] segments) 
Age (yr) 
Mean _+ SD 45.0 _+ 17 50.6 _+ 15 < 0.001 45.0 _+ 16 < 0.001 40.3 + 18 < 0.001 
Range 7 79 7-78 7-79 7-77 
Male 393 (66%) 117 (69%) NS 145 (65%) NS 131 (65%) NS 
Female 207 (34%) 53 (32%) 83 (35%) 71 (35%) 
Functional c ass 
(NYHA) 
I 182 (30%) 52 (31%) NS 78 (34%) < 0.05 52 (26%) NS 
II 282 (47%) 76 (45%) NS 103 (45%) NS 103 (51%) NS 
Ill/IV 136 (.:, ,c ) 42 (25%) NS 47 (20%) NS 47 (23%) NS 
LV wall thickness 
(mm) 
. . . .  + Mean _- SD ~ - 5 20 _ 3 < 0.001 22 _+ 4 < 0.001 25 -+ 6 < 0.00l 
-<20 mm 269 (45%) 115 (68%) < 0.001 99 (43%) < 0.001 55 (27%) < 0.001 
->30 mm 68 (11%) 3 (2%) < 0.001 18 (8%) < 0.001 47 (23%) < 0.001 
Degree of SAM* 
Absent ~.~ (38 c) 82 (48%) < 0.05 89 (39%) < 0.05 55 (27%) < 0.001 
Mild/moderate 170 (28%) 46 (27%) NS 65 (28%) NS 59 (30%) NS 
Severc 204 (34%) 42 (25%) < 0.05 74 (33%) < 0.05 88 (43%) < 0.001 
Pattern of hypertrophy, 
longitudinal plane 
Basal > apical 173 (29e~) 83 (49%) < 0.001 54 (24%) NS 36 (18%) < 0.001 
Basal = apical 217 (36q~) 45 (26%=) < 0.01 9l (40%) NS 81 (40%) < 0.01 
Apical > basal 210 (35%) 42 (25%) < 0.001 83 (36%) NS 85 (42%) < 0.001 
*Magnitude ofsystolic anterior motion of mitral valve (SAM) was asses~d using a modification f the grading system of Gilbert et al. (32): mild = approaches 
ventricular septum, but without mitral valve-septal contact; moderate = brief mitral-septal contact; and severe = prolonged mitral-septal contact, >30% of 
echocardiographic systole. Unless otherwise indicated, ata presented are number (%) of patients. LV = left ventricular; NYHA = New York Heart Association. 
expressions occurred. Given the smaller body size of women, 
this finding was somewhat unexpected, and probably largely 
reflects the fact that hypertrophic cardiomyopathy is a primary, 
genetically determined cardiac disease (1,2,4,6,9,10). Also, we 
did not identify in the present study a relation between the 
extent of hypertrophy and the magnitude of patient symptoms, 
a finding at some variance with earlier cross-sectional nalyses 
in hypertrophic cardiomyopathy showing mild but statistically 
Figure 7. Distribution of left ventricular (LV) hypertrophy as assessed 
with echocardiography in 600 patients with hypertrophic cardiomyop- 
athy, shown with respect to the number of hypertrophied left ventric- 
ular segments, as well as gender. Solid bars = men; hatched bars 
women. 
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40 0.001 -~ NS - 
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significant correlations between greater degrees of hypertro- 
phy and cardiac symptoms (8). These discrepancies are prob- 
ably explained largely on the basis of the added statistical 
power conveyed in this study with a particularly large patient 
cohort, or possibly by differences in patient referral patterns. 
Study l imitations. It should be emphasized that the cohort 
with hypertrophic ardiomyopathy evaluated here is tertiary 
referral based and, as a consequence, may be subject to 
considerable patient selection bias (46,47). Therefore, the 
reported frequencies with which different patterns of left 
Figure 8. Relation of number of hypertrophied left ventricular (LV) 
segments o maximal wall thickness in 600 patients with hypertrophic 
cardiomyopathy. 
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Figure 9, Relation of distribution of left ventricular (LV) hypertrophy 
to the presence of marked systolic anterior motion of the mitral valve 
with mitral-septal contact (SAM) in 600 patients with hypertrophic 
cardiomyopathy. 
ventricular hypertrophy occurred may not be entirely repre- 
sentative of the general patient population and disease spec- 
trum of hypertrophic cardiomyopathy (48). Nevertheless, we 
believe that the substantial size of our study group conveys an 
important measure of credibility to the overall data and 
conclusions. 
Relevance to molecular biology. The phenotypic heteroge- 
neity we observed in hypertrophic cardiomyopathy may be 
related to a number of possible determinants. Morphoiogic 
diversity could be a reflection of the genetic heterogeneity 
characteristic of hypertrophic cardiomyopathy (4,6,49,50). For 
example, molecular abnormalities in genes encoding for four 
proteins of the sarcomere (beta-myosin heavy chain, cardiac 
troponin T, alpha-tropomyosin and myosin-binding protein-C) 
have been reported to date in families with this disease 
(4,6,49-51), and linkage to several other genes is also likely. 
Furthermore, many mutations for each of these different gene 
abnormalities have been described (49,52), including -35 
missense mutations in the beta-myosin heavy-chain gene. 
Therefore, ultimately, there may be a particularly substantial 
number of genes and mutations responsible for the wide 
variety of phenotypes vident in hypertrophic cardiomyopathy. 
However, this hypothesis probably cannot completely explain 
the phenotypic heterogeneity evident in the present study; for 
example, it is also known that a diversity of patterns of left 
ventricular hypertrophy may be present in family members 
Figure I0. Relation of number of hypertrophied left ventricular (LV) 
segments to patient age in 600 patients with hypertrophic ardiomy- 
opathy. 
60 <0.001 , 
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within individual hypertrophic cardiomyopathy pedigrees hav- 
ing the same genetic substrate (53,54). Therefore, alterna- 
tively, it is possible that polymorphism in the form of additional 
modifying gene abnormalities, environmental factors or un- 
known random influences may play a role in the morphologic 
expression of hypertrophic cardiomyopathy, including the dis- 
tribution of hypertrophy evident on echocardiogram. 
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